News & Updates | Alliance Healthcare UK

Updates

SUB-TYPE: CLASS 3 RECALL

Class 3 Recall - Field Safety Notice on Super Absorbent Dressing

Richardson Healthcare has released a field safety notice for the below batches of Super Absorbent Dressing after carrying out a stock check of the Sterile Super Absorbent Dressing and found the afore mentioned six batch numbers of the Sterile Super Absorbent Dressing are missing the paper IFU insert in their inner boxes.

This is a Caution in Use Class 3 Recall - Field Safetly Notice Only.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3925351	Super Absorbent dressing, 7.5 x 7.5 cm	Richardson Healthcare	190328
3925369	Super Absorbent dressing, 10 x 10 cm	Richardson Healthcare	190408
3925377	Super Absorbent dressing, 10 x 20 cm	Richardson Healthcare	190329
3925401	Super Absorbent dressing, 15 x 25 cm	Richardson Healthcare	190330
3925385	Super Absorbent dressing, 20 x 20 cm	Richardson Healthcare	190407
3925393	Super Absorbent dressing, 20 x 30 cm	Richardson Healthcare	190331

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

This is an NWOS only recall and unfortunately we can only accept stock purchased from us Alliance Healthcare Distribution Limited. Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: FMD ALERT

FMD Alert: Class 2 Recall on Kosei Pharma, Mpt Pharma, Doncaster Pharma, Drugsrus Ltd/P.I.E Phara PI

Kosei Pharma UK Ltd, MPT Pharma Ltd, Doncaster Pharmaceuticals Group Ltd & Drugsrus Ltd / P.I.E. Pharma Ltd are recalling various parallel imported products (PI) as it has come to our attention that these medicines have been taken out of the regulated medicines' supply chain during distribution and later re-introduced. This means that the correct transport and storage conditions cannot be guaranteed during this period and, whilst unlikely, could impact their effectiveness. The products are believed to be legitimate. There is no evidence that they have been tampered with and these medicines are stable at room temperature. Following the issue of FMD Alert EL (19)A/15 on 27 June 2019, we have become aware that Kosei Pharma UK Ltd, CST Pharma Ltd and Ordinant Medical Solutions Ltd have also parallel imported some affected products into the UK from Italy and they have been re-labelled in Kosei Pharma UK Ltd, MPT Pharma Ltd, Drugsrus Ltd / P.I.E. Pharma Ltd and Doncaster Pharmaceuticals Group Ltd livery.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

Recall Details
Please refer to the MHRA link above for product details and affected batch details.

Only Kosei Pharma UK Ltd, MPT Pharma Ltd, Doncaster Pharmaceuticals Group Ltd & Drugsrus Ltd / P.I.E. Pharma Ltd liveries are within the scope of this Alert.

For Kosei Pharma UK Ltd general enquiries please contact Mr. Saket Jadhav Tel: 01753515054: Email: saket.j@koseipharma.com

For Kosei Pharma UK Ltd medical information enquiries please contact Mr. Kalpesh Patel Tel: 01753515050: Email: Kalpeshkumar.p@koseipharma.com

For MPT Pharma Ltd all enquiries please email productrecalls@mptpharma.co.uk

For Doncaster Pharmaceuticals Group Ltd all enquiries please email Rachael Hill, Email: rachael.hill@doncaster-pharm.com Tel 01302 554804 or Richard Gore, Email: richard.gore@doncaster-pharm.com Tel: 01302 554805

For Drugsrus Ltd / P.I.E. Pharma Ltd all enquiries please contact Drugsrus Customer Services, Email: recall@drugsrus.co.uk Tel: 020 8423 3800

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Bisacodyl Tab 5mg X 1000

Chanelle Medical is recalling the below batch because a small number of packs have been found to contain tablets which are stuck together, with mould observed on some tablets. The mould has been identified as a Penicillium species. It is unlikely that affected tablets will have got to patient level as the sticking is noticeable on opening the pack..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
8096331	BISACODYL TAB 5MG X 1000	CHANELLE MEDICAL	25074A

For stock enquiries please contact David Hammond, General Manager, Healthcare Pharma: Tel: 01233 822 297 Email: rp@healthcarepharma.co.uk.

For medical information enquiries please contact Anne Dougherty, Operations Director, Panacea Pharma Projects, Isle of Man: Tel: 44-1624 672777 Email: anne.dougherty@panacea.im.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in Use on Emerade 150, 300, 500 Micrograms Pfs

Bausch & Lomb UK limited has informed us of a risk of Emerade product failing to deliver a dose of adrenaline from the syringe due to blockage of the needle.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
3849221	EMERADE 150 AUTO-INJECTOR	BAUSCH & LOMB UK	ALL STOCK
3849239	EMERADE 300 AUTO-INJECTOR	BAUSCH & LOMB UK	ALL STOCK
3849247	EMERADE 500 AUTO-INJECTOR	BAUSCH & LOMB UK	ALL STOCK

Please note that Alliance Healthcare do not stock and as this is a caution in use only we are not accepting stock returns.

For stock enquiries please contact Bausch & Lomb Customer Services: Tel: 0208 781 2991 Email: Pharma_CS@bausch.com.

For medical information enquiries please contact Lizanne Kombrink, Pharmacovigilance and Medical Information Officer: Tel: 0208 781 5523 Email: Pharmacovigilance.UK@bausch.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Recall on Potassium Chloride

Baxter Healthcare Limited has informed us that a quality defect has been identified with the above products where the front panel of a small number of infusion bags was found to be missing the red text.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
ALLIANCE DO NOT STOCK	POTASSIUM CHLORIDE 0.15% W/V AND GLUCOSE 10% W/V SOLUTION FOR INFUSION, 500ML	BAXTER HEALTHCARE LIMITED	PLEASE REFER TO THE ABOVE LINK FOR BATCH NUMBERS
ALLIANCE DO NOT STOCK	POTASSIUM CHLORIDE 0.15% W/V AND SODIUM CHLORIDE 0.9% W/V SOLUTION FOR INFUSION – BP, 1000ML	BAXTER HEALTHCARE LIMITED	PLEASE REFER TO THE ABOVE LINK FOR BATCH NUMBERS
ALLIANCE DO NOT STOCK	POTASSIUM CHLORIDE 0.3% W/V AND SODIUM CHLORIDE 0.9% W/V SOLUTION FOR INFUSION, 1000ML	BAXTER HEALTHCARE LIMITED	PLEASE REFER TO THE ABOVE LINK FOR BATCH NUMBERS

For stock control enquiries and medical Information enquiries please contact Baxter by email: uk_shs_qa_complaints@baxter.com or by telephone: 01604 704 603 (Baxter reference number: FA-2019-026).

Please note that Alliance Healthcare do not stock and as this is a caution in use only we are not accepting stock returns.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company-Led Recall on DOCETAXEL VIAL 20MG PFZ 2ML & DOCETAXEL VIAL 160MG PFZ 16ML

Pfizer UK Limited is recalling the below batches. This is because routine stability testing has identified that levels of a known impurity, 10-oxo-docetaxel, may exceed the acceptable level at end of shelf-life.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
8120875	DOCETAXEL VIAL 20MG PFZ 2ML	PFIZER LTD	S0150518
8120867	DOCETAXEL VIAL 160MG PFZ 16ML	PFIZER LTD	S0390218 S0120218

Please do not consolidate any stock for return. All returns must be from the original delivery address. Any product(s) returned from non-Pfizer accounts will be retained by the distribution centre and not returned. Credit for these returned products must be obtained from the supplier from where the product was purchased.

All Stock must be returned to Alliance Healthcare before the 19th September 2019.

For medical information please contact Pfizer Medical Information Department on 01304 616161

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Co-Amoxiclav 125 Mg/31.25 Mg/5 Ml & 25 Mg/62.5 Mg/5 Ml Powder For Oral Suspension

Sandoz Ltd. have been notified of a potential packaging problem relating to poor seal adherence which could cause clumping of the powder within the bottle. A poor bottle seal could lead to degradation of the clavulanic acid within the powder and could potentially render the product ineffective..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Supplier	Affected Batch
1086271	CO-AMOXICLAV SF 125/31.25MG	SANDOZ LTD	HT6202 HT7923
1117290	CO-AMOXICLAV 31/125MG/5ML	SANDOZ LTD	HT6202 HT7923
1086289	CO-AMOXICLAV 250/62MG	SANDOZ LTD	HT6202 HT7923
1117308	CO-AMOXICLAV SF 250/62.5MG	SANDOZ LTD	HT6202 HT7923

For enquiries relating to stock returns please contact Sandoz Limited Customer Services on 01276 698607 or email sales.sandoz-gb@sandoz.com

For Medical information enquiries, please contact Sandoz Medical Information Team on 01276 698101or email sandozgb@EU.propharmagroup.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in Use on Prednisolone Tab 5mg

Genesis Pharmaceuticals Ltd has informed us that there is an error on the Braille for the above batches which means that the strength reads as 1mg instead of 5mg. The printed text is correct on all packaging.

Please visit the: MHRA website for more details on this drug alert

The affected products' details are as follows:

For further information please contact Genesis Pharmaceuticals Ltd, tel. 020 7201 0400.

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

PIP Code	Product Description	Supplier	Affected Batches
1110840	PREDNISOLONE TAB 5MG ALM	ALMUS PHARMACEUTICALS LTD	1809653 1809654 1809655 1809656 1809657
1057363	PREDNISOLONE TAB 5MG ACT	ACCORD SCHEME	1809653 1809654 1809655 1809656 1809657
1057132	PREDNISOLONE TAB 5MG TEV	TEVA UK LTD	1809653 1809654 1809655 1809656 1809657
1052893	PREDNISOLONE TAB 5MG CP	WOCKHARDT ETHICAL(MOV)	1809653 1809654 1809655 1809656 1809657

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Valsartan

Teva UK Limited and Mylan are recalling some Valsartan containing products including certain batches supplied by Teva UK Limited and all unexpired batches supplied by Mylan.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code	Product Description	Livery	Affected Batches
8466179	VALSARTAN TAB 40MG	TEVA UK LIMITED	100350 100938 101776
1166909	VALSARTAN TAB 40MG TEV	TEVA UK LIMITED	100350 100938 101776
1167535	VALSARTAN TAB 40MG GUK	TEVA UK LIMITED	100350 100938 101776
1161546	VALSARTAN TAB 40MG ACT	TEVA UK LIMITED	100350 100938 101776
8466245	VALSARTAN TAB 320MG	TEVA UK LIMITED	100433 101777
1166917	VALSARTAN TAB 320MG TEV	TEVA UK LIMITED	100433 101777
1173152	VALSARTAN TAB 320MG ACT	TEVA UK LIMITED	100433 101777
1166958	VALSARTAN HCTZ TAB80/12.5MG TEV	TEVA UK LIMITED	6P601163 6P606333 0001584 0002626 0002627 0003214 0004744
8466203	VALSARTAN HCTZ TAB 80MG/12.5MG	TEVA UK LIMITED	6P601163 6P606333 0001584 0002626 0002627 0003214 0004744
1161520	VALSARTAN HCT TAB 80/12.5MG ACT	TEVA UK LIMITED	6P601163 6P606333 0001584 0002626 0002627 0003214 0004744
8466161	VALSARTAN HCTZ TAB 160MG/25MG	TEVA UK LIMITED	6P601084 6P606270 0000350 0000352 0001997 0002338 0003615
1166941	VALSARTAN HCT TAB 160/25MG TEV	TEVA UK LIMITED	6P601084 6P606270 0000350 0000352 0001997 0002338 0003615
1162353	VALSARTAN HCT TAB 160/25MG ACT	TEVA UK LIMITED	6P601084 6P606270 0000350 0000352 0001997 0002338 0003615
8466195	VALSARTAN HCTZ TAB 160MG/12.5MG	TEVA UK LIMITED	6P607166 0000426 0001520 0001521 0002298 0003663 0004670
1166966	VALSARTAN HCT TAB 160/12.5MG TEV	TEVA UK LIMITED	6P607166 0000426 0001520 0001521 0002298 0003663 0004670
1161538	VALSARTAN HCT TAB 160/12.5MG ACT	TEVA UK LIMITED	6P607166 0000426 0001520 0001521 0002298 0003663 0004670
1167626	VALSARTAN CAPSULES 80MG ACT	MYLAN	ALL STOCK
1166883	VALSARTAN CAP 80MG TEV	MYLAN	ALL STOCK
8466229	VALSARTAN CAP 80MG	MYLAN	ALL STOCK
1166214	VALSARTAN CAP 80 MG GUK	MYLAN	ALL STOCK
1166875	VALSARTAN CAP 40MG TEV	MYLAN	ALL STOCK
1167618	VALSARTAN CAP 40MG ACT	MYLAN	ALL STOCK
8466237	VALSARTAN CAP 40MG	MYLAN	ALL STOCK
1166206	VALSARTAN CAP 40 MG GUK	MYLAN	ALL STOCK
1166891	VALSARTAN CAP 160MG TEV	MYLAN	ALL STOCK
8466211	VALSARTAN CAP 160MG	MYLAN	ALL STOCK
1166222	VALSARTAN CAP 160 MG GUK	MYLAN	ALL STOCK
1167634	VALSARTAN CAPSULES 160MG ACT	MYLAN	ALL STOCK

Teva UK Limited

For stock control: general.enquiries@tevauk.com

For medical information enquiries: medinfo@tevauk.com

Mylan

For stock control: mguk_customer.services@mylan.co.uk, 01707 853100

For medical information enquiries: info@mylan.co.uk, 01707 853 000, Option 1

Any stock returned after the 30th April 2019 will not receive credit.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Recall on Zoledronic acid 5mg solution for infusion

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from the above batch contain a Patient Information Leaflet (PIL) for Temozolomide 180mg Capsules..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch

1186964Zoledronic acid 5mg solution for infusionRanbaxy (UK) LtdJKT1576A

For any enquiries, please contact Ranbaxy / Sun Pharmaceuticals customer services team: Tel: 020 8848 5050; email: cserv.uk@sunpharma.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.